18 Members•4,119 Posts

Pharma & Biotech

Poolbeg Pharma gets positive FDA feedback for development pathway of lead cancer therapy asset

May 26, 2026

Ian Lyall

Eli Lilly weight loss drug data supports long-term obesity market position, says UBS

May 25, 2026

Emily Jarvie

Inside Biotech: Lilly’s retatrutide raises the bar again in the obesity drug race

May 25, 2026

Lisa Uhlman

Bram Goorden discusses IXICO growth plans - ICYMI

May 24, 2026

Ian Lyall

OKYO Pharma expands scientific advisory board with cornea expert - ICYMI

May 23, 2026

Emily Jarvie

Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI

May 22, 2026

Angela Harmantas

Novo Nordisk faces new GLP-1 rival as Eli Lilly's triple agonist sets weight-loss record

May 22, 2026

Ian Lyall

Alcidion builds scale through Telstra Health deal - ICYMI

May 22, 2026

Jonathan Jackson

Imugene flags strong early azer-cel responses ahead of ASCO spotlight

May 22, 2026

Lisa Uhlman

Creo Medical shares surge 27% on proposed sale of remaining European stake

May 22, 2026

Ian Lyall

Creo Medical Group to raise £5.5m and advance partial divestment

May 22, 2026

Jamie Ashcroft

Imugene's Azer-Cel delivers 81% response rate in heavily pre-treated patients

May 22, 2026

Kerry Stevenson

Tiziana completes enrollment for Phase 2 trial in progressive MS study

May 21, 2026

Steve Darling

Inside Biotech: OncoSil’s TGA breakthrough puts focus back on pancreatic cancer challenge

May 21, 2026

Lisa Uhlman

Tiziana Life Sciences completes enrollment in Phase 2a multiple sclerosis trial

May 21, 2026

Emily Jarvie

IXICO contract wins provide near-total revenue visibility for current year

May 21, 2026

Ian Lyall

Avecho completes treatment phase for Phase III insomnia trial interim analysis

May 21, 2026

Jonathan Jackson

IXICO, Ilika, EMV Capital, Zephyr Energy, Metals One, Bradda Head Lithium - Small Cap Snapshot

May 21, 2026

Stephen Gunnion

EMV Capital's AMR Bio advances infection-prevention drug towards phase III trial

May 21, 2026

Ian Lyall

IXICO wins £1.3 million in Alzheimer's and Huntington's contracts

May 21, 2026

Ian Lyall

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy